ResearcherUniversity of Southern CaliforniaActive in the last 2 years
Steven R. Grossman
Matched on ORCID iD 0009-0003-4692-6925; OpenAlex author ID A5011412916. Sources: ClinicalTrials.gov.
Their work
- Papers
- 10 (first author 0, last author 4)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 1
- Collaborators
- 27
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers, 1 trial · 2024: 2 papers
Papers 10
- Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study. Co-author DOI 10.1016/j.xcrm.2023.101391↗
- Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study. Co-author DOI 10.1016/j.xcrm.2024.101842↗
- Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma. Last author DOI 10.1038/s41389-023-00498-8↗
- Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promising Novel Therapy for Pancreatic Cancer. Last author DOI 10.1158/2767-9764.crc-22-0521↗
- Rising Incidence and Racial Disparities of Early-Onset Pancreatic Cancer in the United States, 1995-2018. Co-author DOI 10.1053/j.gastro.2022.03.011↗
- Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation. Co-author DOI 10.1002/onco.13758↗
- CtBP-a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma. Last author DOI 10.1038/s41389-019-0163-x↗
- Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid. Co-author DOI 10.1158/0008-5472.can-14-0819↗
- A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma. Last author PMID 24312684↗
- The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis. Co-author DOI 10.1158/1541-7786.mcr-10-0475↗
Trials 1
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Brian Z. Huang · 3 shared papers, 2022–2024 · strength 0.55
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2023.101391↗
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2024.101842↗
- Paper Rising Incidence and Racial Disparities of Early-Onset Pancreatic Cancer in the United States, 1995-2018. DOI 10.1053/j.gastro.2022.03.011↗
- Veronica Wendy Setiawan · 3 shared papers, 2022–2024 · strength 0.55
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2023.101391↗
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2024.101842↗
- Paper Rising Incidence and Racial Disparities of Early-Onset Pancreatic Cancer in the United States, 1995-2018. DOI 10.1053/j.gastro.2022.03.011↗
- Heinz‐Josef Lenz · 3 shared papers, 2022–2024 · strength 0.55
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2023.101391↗
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2024.101842↗
- Paper Rising Incidence and Racial Disparities of Early-Onset Pancreatic Cancer in the United States, 1995-2018. DOI 10.1053/j.gastro.2022.03.011↗
- Kranthi Kumar Chougoni · 3 shared papers, 2019–2023 · strength 0.47
- Paper Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promi… DOI 10.1158/2767-9764.crc-22-0521↗
- Paper Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibitio… DOI 10.1038/s41389-023-00498-8↗
- Paper CtBP-a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma. DOI 10.1038/s41389-019-0163-x↗
- Samantha A. Streicher · 2 shared papers, 2024 · strength 0.40
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2023.101391↗
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2024.101842↗
- Lang Wu · 2 shared papers, 2024 · strength 0.40
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2023.101391↗
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2024.101842↗
- Hajime Yamazaki · 2 shared papers, 2024 · strength 0.40
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2023.101391↗
- Paper Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mend… DOI 10.1016/j.xcrm.2024.101842↗
- Martin Michael Dcona · 2 shared papers, 2023 · strength 0.38
- Paper Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promi… DOI 10.1158/2767-9764.crc-22-0521↗
- Paper Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibitio… DOI 10.1038/s41389-023-00498-8↗
- Lihua Liu · 1 shared paper, 2022 · strength 0.15
- Stephen Jacob Pandol · 1 shared paper, 2022 · strength 0.15
- Reginald Hill · 1 shared paper, 2022 · strength 0.15
- Ulka N. Vaishampayan · 1 shared paper, 2021 · strength 0.13
- Shumei Kato · 1 shared paper, 2021 · strength 0.13
- Dana Backlund Cardin · 1 shared paper, 2021 · strength 0.13
- Patricia Mucci LoRusso · 1 shared paper, 2021 · strength 0.13
- Joseph W. Kim · 1 shared paper, 2021 · strength 0.13
- Ayesha T. Chawla · 1 shared paper, 2019 · strength 0.08
- Paul B. Fisher · 1 shared paper, 2014 · strength 0.04
- Luni Emdad · 1 shared paper, 2014 · strength 0.04
- Praveen Bhoopathi · 1 shared paper, 2014 · strength 0.04
- Bridget A. Quinn · 1 shared paper, 2014 · strength 0.04
- Volkan Çetin · 1 shared paper, 2013 · strength 0.03
- Jennifer F. Tseng · 1 shared paper, 2013 · strength 0.03
- Dawn E Quelle · 1 shared paper, 2011 · strength 0.02
- Viviane Palhares Muniz · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.